Arcus Biosciences, Inc.

Historical 13F Holders

Symbol
RCUS
CUSIP
03969F109
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 03969F109 since 12/18/2024, largest first.

Filer % of Class Filed
Gilead Sciences, Inc. 13D/A 24.7% 8/7/2026
Event 8/5/2026
BlackRock, Inc. 13G/A 10.4% 1/8/2026
Event 12/31/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
Point72 Asset Management, L.P. 13G/A
4.1% 11/14/2025
Event 9/30/2025
Vanguard Group Inc 13G/A 0% 3/26/2026
Event 3/13/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 246 125 M $3.23B
2026 Q2 233 123 M $3.78B
2026 Q1 212 119 M $2.57B
2025 Q4 212 121 M $2.89B
2025 Q3 191 101 M $1.37B
2025 Q2 188 99.7 M $812M
2025 Q1 189 97.2 M $763M
2024 Q4 187 83.9 M $1.25B
2024 Q3 189 53.3 M $815M
2024 Q2 196 52.0 M $791M
2024 Q1 175 52.9 M $998M
2023 Q4 189 52.8 M $1.01B
2023 Q3 189 52.8 M $948M
2023 Q2 184 54.7 M $1.11B
2023 Q1 183 55.5 M $1.01B
2022 Q4 205 53.8 M $1.11B
2022 Q3 185 52.5 M $1.37B
2022 Q2 179 52.4 M $1.33B
2022 Q1 161 50.6 M $1.60B
2021 Q4 148 50.8 M $2.06B
2021 Q3 133 48.3 M $1.68B
2021 Q2 135 45.2 M $1.24B
2021 Q1 152 44.7 M $1.25B
2020 Q4 151 44.6 M $1.16B
2020 Q3 130 44.4 M $761M
2020 Q2 142 41.8 M $1.03B
2020 Q1 93 27.0 M $375M
2019 Q4 76 27.1 M $274M
2019 Q3 76 25.8 M $235M
2019 Q2 79 26.4 M $210M
2019 Q1 65 25.8 M $322M
2018 Q4 68 26.9 M $290M
2018 Q3 59 22.5 M $313M
2018 Q2 64 22.4 M $274M
2018 Q1 57 19.9 M $293M